ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $454,000 | -23.8% | 85,091 | -43.0% | 0.45% | -16.1% |
| Q2 2022 | $596,000 | +29.0% | 149,347 | +43.5% | 0.54% | +70.6% |
| Q1 2022 | $462,000 | +33.1% | 104,042 | +20.0% | 0.32% | +38.6% |
| Q4 2021 | $347,000 | -30.2% | 86,730 | +53.1% | 0.23% | -27.8% |
| Q3 2021 | $497,000 | -4.1% | 56,653 | +23.9% | 0.32% | -4.5% |
| Q2 2021 | $518,000 | +20.2% | 45,731 | +25.9% | 0.33% | +13.4% |
| Q1 2021 | $431,000 | +12.5% | 36,310 | -35.0% | 0.29% | +14.5% |
| Q4 2020 | $383,000 | – | 55,821 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |